Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
CSACI position statement: epinephrine...
Journal article

CSACI position statement: epinephrine auto-injectors and children < 15 kg

Abstract

Epinephrine (adrenaline) is the treatment of choice for anaphylaxis. While other medications, including H1-antihistamines, H2-antihistamines, corticosteroids, and inhaled beta-2 agonists are often used to treat anaphylaxis in the emergency setting, none of these medications has been shown to reverse anaphylaxis. Fatal anaphylaxis is related to the delayed use of epinephrine. In community settings, epinephrine is available as an auto-injector in …

Authors

Halbrich M; Mack DP; Carr S; Watson W; Kim H

Journal

Allergy, Asthma & Clinical Immunology, Vol. 11, No. 1,

Publisher

Springer Nature

Publication Date

December 2015

DOI

10.1186/s13223-015-0086-9

ISSN

1710-1484